These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25167857)

  • 1. Formoterol in the treatment of experimental cancer cachexia: effects on heart function.
    Toledo M; Springer J; Busquets S; Tschirner A; López-Soriano FJ; Anker SD; Argilés JM
    J Cachexia Sarcopenia Muscle; 2014 Dec; 5(4):315-20. PubMed ID: 25167857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
    Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the beta
    Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
    Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
    Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
    Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.
    Busquets S; Toledo M; Marmonti E; Orpí M; Capdevila E; Betancourt A; López-Soriano FJ; Argilés JM
    Oncol Lett; 2012 Jan; 3(1):185-189. PubMed ID: 22740878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
    Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
    Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
    Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
    Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.
    Busquets S; Toledo M; Sirisi S; Orpí M; Serpe R; Coutinho J; Martínez R; Argilés JM; López-Soriano FJ
    Exp Ther Med; 2011 Jul; 2(4):731-735. PubMed ID: 22977567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model.
    Busquets S; Castillejo M; Jové Q; Jude B; Mejías P; López-Soriano FJ; Argilés JM
    Onco Targets Ther; 2021; 14():1953-1959. PubMed ID: 33762827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.
    Salazar-Degracia A; Busquets S; Argilés JM; López-Soriano FJ; Barreiro E
    PeerJ; 2017; 5():e4109. PubMed ID: 29255650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.
    Toledo M; Penna F; Oliva F; Luque M; Betancourt A; Marmonti E; López-Soriano FJ; Argilés JM; Busquets S
    J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):48-59. PubMed ID: 27066318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
    Toledo M; Busquets S; Ametller E; López-Soriano FJ; Argilés JM
    J Cachexia Sarcopenia Muscle; 2011 Mar; 2(1):57-62. PubMed ID: 21475674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
    Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
    Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
    Ryall JG; Sillence MN; Lynch GS
    Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
    Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
    FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived
    Koziczak-Holbro M; Rigel DF; Dumotier B; Sykes DA; Tsao J; Nguyen NH; Bösch J; Jourdain M; Flotte L; Adachi Y; Kiffe M; Azria M; Fairhurst RA; Charlton SJ; Richardson BP; Lach-Trifilieff E; Glass DJ; Ullrich T; Hatakeyama S
    J Pharmacol Exp Ther; 2019 May; 369(2):188-199. PubMed ID: 30819762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.
    Florea VG; Moon J; Pennell DJ; Doehner W; Coats AJ; Anker SD
    Int J Cardiol; 2004 Oct; 97(1):15-20. PubMed ID: 15336800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac wasting in head and neck cancer and in cardiac autopsies from different cancer types: A study in a chemo-naïve setting.
    Calamelli S; Noto S; Baldoni A; Casarin A; Calzavara A; Bolgan I; Coccato S; Saccà S; Laurino L; Azzarello G; Ausoni S
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1286-1298. PubMed ID: 36999538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.